Low Cost Microphysiological System for Improved Pharmacodynamics

Information

  • Research Project
  • 9048711
  • ApplicationId
    9048711
  • Core Project Number
    R43GM117954
  • Full Project Number
    1R43GM117954-01
  • Serial Number
    117954
  • FOA Number
    PA-14-071
  • Sub Project Id
  • Project Start Date
    2/1/2016 - 9 years ago
  • Project End Date
    7/31/2016 - 9 years ago
  • Program Officer Name
    COLE, ALISON E.
  • Budget Start Date
    2/1/2016 - 9 years ago
  • Budget End Date
    7/31/2016 - 9 years ago
  • Fiscal Year
    2016
  • Support Year
    01
  • Suffix
  • Award Notice Date
    1/27/2016 - 9 years ago
Organizations

Low Cost Microphysiological System for Improved Pharmacodynamics

? DESCRIPTION (provided by applicant): The high failure rate of drugs in late stage development, nearly 90%, is a symptom of the inadequacy of pre-clinical animal models to accurately predict human biology. One of the major reasons drugs fail in the clinic is inaccurate prediction of the therapeutic index: which is the dose range where drugs are effective and also not toxic. Failure to identify metabolism produced toxicities in preclinical efforts lead to unwelcome and highly expensive surprises in clinical trials and even post-marketing of new drugs. SciKon has created a serial capillary system in a standard cell culture format that enables researchers to apply drugs to cells in culture using a more in-vivo-like exposure dynamic. In turn a compartmentalized dynamic gradient enables query of each internal serial system for evaluating cellular mechanisms in both a concentration and time-resolved manner. This proposal describes using this system to query cytotoxicity of drugs to primary human hepatocytes as a function of the real time changes in parent: metabolite ratio. Our preliminary tests suggests the feasibility of creating a screening assay that distinguishes between whether a test chemical is metabolized to something toxic or not without a priori understanding of a drugs' overall metabolism or metabolite ID. The aims of this proposal are to 1) quantitate metabolites of common test compounds as a function of both time, parent concentration, and location within the system and 2) to evaluate a 11 compound training set of drugs with known hepatotoxicity in the clinic as well as the metabolic component of that toxicity. Such an assay can be inserted into the drug development pipeline much earlier than current hepatocyte metabolism studies where knowing the metabolite ID is a prerequisite, thus reducing the overall cost of drug development and increasing the chances of success in the clinic. Furthermore, this assay would also apply to chemicals for industrial, consumer product, cosmetics, and foods.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    199623
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:199623\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SCIKON INNOVATION, INC.
  • Organization Department
  • Organization DUNS
    830397506
  • Organization City
    RESEARCH TRIANGLE PARK
  • Organization State
    NC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    277090003
  • Organization District
    UNITED STATES